Details for New Drug Application (NDA): 083914
✉ Email this page to a colleague
NDA 083914 describes LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% profile page.
The generic ingredient in LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
The generic ingredient in LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
Summary for 083914
| Tradename: | LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% |
| Applicant: | Hospira |
| Ingredient: | lidocaine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SPINAL | Strength | 5% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
